This is an international site for FEMARA
®
(letrozole) and is intended for Health Care Professionals outside
the U.S. The information on the site is not country-specific, and may contain information that is outside the
approved indications in the country in which you are located. Please contact your local Novartis
representative for the latest information specific to your country.
The Femara
®
International Website For Non US Healthcare Professionals Only
>> For US Residents
>> Country Sites
>> European Summary of Product Characteristics
Site Map
Home
About Femara
®
Making a Difference
Mechanism of Action Video
Dosage and Administration
European Summary of Product Characteristics
Adjuvant Therapy
Risks in Early Breast Cancer
BIG 1-98 Trial Design
BIG 1-98 Efficacy Results
BIG 1-98 Safety Results
Extended Adjuvant Therapy
MA-17 Trial Design
MA-17 Efficacy Results
MA-17 Safety Results
Femara
®
Interactive
Patient Case Studies
Profile - Michelle
Profile - Emma
Profile - Annette
Profile - Astrid
BIG 1-98 Challenge
Resources
Publications and Guidelines
Links to Websites
Upcoming Events
Additional Resources
For US Residents
Country Sites
European Summary of Product Characteristics
About Novartis Oncology
Site Map
Safety
Privacy Policy
Terms of Use
Contact Us
Help
